DX-D IMAGING PACKAGE

K122736 · Agfa Healthcare N.V. · MQB · Mar 11, 2013 · Radiology

Device Facts

Record IDK122736
Device NameDX-D IMAGING PACKAGE
ApplicantAgfa Healthcare N.V.
Product CodeMQB · Radiology
Decision DateMar 11, 2013
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.1680
Device ClassClass 2
AttributesPediatric

Intended Use

Agfa's DX-D Imaging Package is indicated for use in general projection radiographic applications to capture for display diagnostic quality radiographic images of human anatomy for adult, pediatric and neonatal examinations. The DX-D Imaging Package may be used wherever conventional screen-film systems, CR or DR systems may be used. Agfa's DX-D Imaging Package is not indicated for use in mammography.

Device Story

Direct radiography imaging system; captures/digitizes x-ray images using flat-panel detectors (Cesium Iodide or Gadolinium Oxysulfide scintillators). X-rays incident on scintillator generate light; photo-detectors convert light to digital signal. Data processed by Agfa NX workstation using MUSICA2 (Multi-Stage-Image-Contrast-Amplification) software; enhances diagnostically relevant, moderate, and subtle contrasts. Used in clinical settings by radiology staff; images viewed on PC/medical displays. Output supports diagnostic decision-making; benefits include direct digital capture without separate digitizer, improved workflow, and optimized image contrast for various patient populations.

Clinical Evidence

No clinical trials; bench testing only. Evidence includes laboratory image quality measurements and in-hospital image comparison studies conducted by independent radiologists to validate system performance.

Technological Characteristics

Scintillator-photodetector solid-state x-ray imaging system. Detectors: Cesium Iodide (CsI) or Gadolinium Oxysulfide (GOS). Connectivity: DICOM. Software: MUSICA2 image processing. OS: Windows 7. Standards: IEC 60601-1, IEC 60601-1-2, ACR/NEMA PS3.1-3.18 (DICOM), ISO 14971, ISO 13485.

Indications for Use

Indicated for general projection radiographic imaging of human anatomy in adult, pediatric, and neonatal populations. Not indicated for mammography.

Regulatory Classification

Identification

A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Special Controls

*Classification.* Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Agfa HealthCare NV Premarket Notification: DX-D Imaging Package MAR 1 1 2013 K122736 Page 1 of 4 # ్ల గ్రామం ### 510(K) SUMMARY: AGFA DX-D Imaging Package Common/Classification Name: Stationary X-ray System, 21 CFR 892.1680 Proprietary Name: DX-D Imaging Package Agfa HealthCare N.V. Septestraat 27 B-2640 Mortsel Belgium Contact: Phil Cuscuna, Prepared: September 4, 2012 Telephone: (416) 240-7317 Facsimile: (416) 240-7359 #### LEGALLY MARKETED PREDICATE DEVICES A. This is a 510(k) for the latest version of Agfa's DX-D Imaging Package, a solid state, flat-panel x-ray imaging system. #### DEVICE DESCRIPTION B. The device is a direct radiography imaging system of similar design and construction to the original (predicate) version of the device. Agfa's DX-D Imaging Package uses the company's familiar NX workstation with MUSICA2™ image processing and flat panel detectors of the scintillator-photodetector type. Flat panel detectors with scintillators of both Cesium Iodide (Csl) and Gadolinium Oxysulfide (GOS) are available. The device is used to capture and directly digitize x-ray images without a separate digitizer. This new version includes optional image processing algorithms for adult, pediatric and neonatal images that were previously cleared for use in Agfa's computed radiography systems. The device uses a direct conversion process to convert x-rays into a digital signal. X-rays incident on the scintillator layer of the detector generate light that is absorbed by photo-detectors, converted to a digital signal and sent to the workstation the data is processed by Agfa's MUSICA image processing software. The acronym MUSICA stands for Multi-Stage-Image-Contrast-Amplification. MUSICA acts on the acquired images to preferentially enhance the diagnostically relevant, moderate and subtle contrasts. Principles of operation and technological characteristics of the new and predicate devices are the same. {1}------------------------------------------------ #### C. INTENDED USE Agfa's DX-D Imaging Package is indicated for use in general projection radiographic applications to capture for display diagnostic quality radiographic images of human anatomy for adult, pediatric and neonatal examinations. The DX-D Imaging Package may be used wherever conventional screen-film systems, CR or DR systems may be used. Agfa's DX-D Imaging Package is not indicated for use in mammography. #### D. SUBSTANTIAL EQUIVALENCE SUMMARY Agfa's DX-D Imaging Package has an Indications For Use statement similar to the statements for the predicate devices, K090672 and K092669. Intended uses are the same. The devices have the same technological characteristics. The new device is physically equivalent to the previous version. K092669 but includes the optional image processing settings utilized in the computed radiography predicate, K090672. Performance data including laboratory image quality measurements and image comparison studies by independent radiologists are adequate to ensure equivalence. Differences in devices do not alter the intended diagnostic effect. {2}------------------------------------------------ K122736 Page 3 of 4 | PRODUCT COMPARISON TABLE | | | | |-----------------------------------|--------------------------------------|--------------------------------------------------------------------------------|--------------------------------------------------------------------------------| | | DX-D Imaging Package<br>(New Device) | AGFA DX-D Imaging<br>Package<br>(PREDICATE-K092669) | AGFA CR Systems with<br>NX Workstations<br>(PREDICATE-K090672) | | Communications | Same as predicates | DICOM | DICOM | | Flat Panel or Image<br>Plate | Same as K092669 | Flat Panel Detector | Image Plates with<br>Cassettes | | Detector Material | Same as K092669 | Gadolinium Oxysulfide<br>(GOS) or<br>Cesium lodide (CSI)<br>scintillator | HD5.0 (CsBr:Eu)<br>MD4.0 (BaSrFBrl:Eu) | | Detector Sizes | Same as K092669 | 17x17 in.<br>14x17 in. | 14x17 in.<br>14x14in.<br>8x10 in.<br>10x12 in | | Active Matrix<br>(14x17 in.) | Same as K092669 | 2560x3072 | 3408 x 4200 (HD5.0)<br>2320 x 2832 (MD4.0) | | Pixel size | Same as K092669 | 139 µm | 100 µm | | Dynamic Range | Same as K092669 | 14 bit | 12 bit | | Maximum Image<br>Acquisitions/hr. | Same as K092669 | 150 | 100 | | Power Supply | Same as predicates | 50-60 Hz<br>100-240V auto ranging | 50-60 Hz<br>100-240V auto ranging | | Operator<br>Workstation | Same as predicates | Agfa NX | Agfa NX | | Image processing | Same as K090672 | MUSICA2 | MUSICA2<br>MUSICA2 Platinum<br>MUSICA2 Neonatal | | Operating system | Windows 7 | Windows XP Pro | Windows XP Pro | | Display System | Same as predicates | Standard PC display or<br>separately cleared medical<br>display (e.g. K051901) | Standard PC display or<br>separately cleared medical<br>display (e.g. K051901) | #### TECHNOLOGICAL CHARACTERISTICS E. Agfa's DX-D Imaging Package is a scintillator-photodetector type solid state x-ray imaging system. The NX workstation allows users to view and processes images, and forward them to other devices (e.g. a PACS or printer). The DX-D Imaging Package is integrated with compatible x-ray systems. #### TESTING F. Image quality measurement data has been provided. In-hospital image quality comparisons have been conducted with qualified independent radiologists as well. Sample images have been {3}------------------------------------------------ K122736 Page 4 of 4 ### provided. Performance of the complete system has been validated. The product, manufacturing and development processes conform to product safety and medical imaging standards including: ## PRODUCT STANDARDS - IEC 60601-1: Medical electrical equipment Part 1: General requirements for basic safety . and essential performance, plus collateral standard: Electromagnetic compatibility requirements and tests. - IEC 60601-1-2: Medical electrical equipment Part 1-2: General Requirements For Safety -. Collateral Standard: Electromagnetic Compatibility - Requirements And Tests - ACR/NEMA PS3.1-3.18: Digital Imaging and Communications in Medicine (DICOM) . ## MANAGEMENT STANDARDS - ISO 14971 Application of Risk Management to Medical Devices . - ISO 13485 Medical Devices Quality Management Systems Requirements For Regulatory ● purposes #### CONCLUSIONS G. This 510(k) has demonstrated Substantial Equivalence as defined and understood in the Federal Food Drug and Cosmetic Act and various guidance documents issued by the Center for Devices and Radiological Health. {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 March 11, 2013 Agfa Healthcare, N.V. % Mr. David Ledwig Principal Consultant Practical Compliance, LLC P.O. Box 1927 BREVARD, NC 28712 Re: K122736 Trade/Device Name: DX-D Imaging Package Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: Class II Product Code: MQB Dated: February 08, 2013 Received: February 12, 2013 Dear Mr. Ledwig: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical {5}------------------------------------------------ Page 2 - Mr. Ledwig device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled; "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, for Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ # Indications for Use 510(k) Number (if known): K122736 Device Name: DX-D Imaging Package Indications For Use: Agfa's DX-D Imaging Package is indicated for use in general projection radiographic applications to capture for display diagnostic quality radiographic images of human anatomy for adult, pediatric and neonatal examinations. The DX-D Imaging Package may be used wherever conventional screen-film systems, CR or DR systems may be used. Agfa's DX-D Imaging Package is not indicated for use in mammography. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR) ![](https://i.imgur.com/99999999999999999999999999999999.png) (Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510 (k) : K122736 Page 1 of 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%